Featured


August 26, 2021

William J. Steinbach, M.D., Joins UAMS as Chair of Department of Pediatrics

Linda Satter

portrait of William Steinbach, M.D., and UAMS logo

William J. Steinbach, M.D., will join the University of Arkansas for Medical Sciences (UAMS) as chair of the Department of Pediatrics and associate dean for Child Health in the UAMS College of Medicine, as well as pediatrician-in-chief of Arkansas Children’s, effective Jan. 15, 2022. “We are thrilled to have Dr. Steinbach join UAMS as we…


August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).


August 24, 2021

UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8

Marty Trieschmann

"Be A Part of The Cure" and text or call in your donation in support of our cancer research efforts.

Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…


August 23, 2021

UAMS Researchers Awarded $2.5 Million Grant to Create Phone App to Prevent Opioid Use Relapse

Tim Taylor

Andrew James, Ph.D., a neuroimaging scientist in UAMS’ Brain Imaging Research Center, seeks to understand how the reward systems of the brain change during recovery from opioid use disorder.

LITTLE ROCK — A team of UAMS research scientists has been awarded a five-year grant worth $2.5 million from the National Institute on Drug Abuse to determine if a cell phone application can reduce the relapse rate in people with opioid use disorder.


August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.


August 13, 2021

UAMS’ Ear, Nose & Throat Department Ranked Among Top 50 in Nation for Third Consecutive Year

Linda Satter

US News/UAMS logo

For the third year in a row, the ear, nose and throat (ENT) department at the University of Arkansas for Medical Sciences (UAMS) has been ranked among the top 50 nationwide by U.S. News & World Report. The digital news and information company that is the global leader in quality rankings also recognized UAMS as…


August 11, 2021

College of Pharmacy Welcomes Students to NCPA Foundation-UAMS Pharmacy Ownership & Leadership Academy

Karmen Robinson

Pharmacy students work on their group business plan during the NCPA Foundation-UAMS Pharmacy Ownership & Leadership Academy.

The UAMS College of Pharmacy hosted its third NCPA Foundation-UAMS Pharmacy Ownership & Leadership Academy on the Little Rock campus with 29 fully vaccinated students from 19 states.


August 10, 2021

UAMS Research Sheds Light on Vaccine Hesitancy in Arkansas

David Wise

Vaccines are available at multiple locations across the state of Arkansas.

Researchers at UAMS have found that trust in vaccines, fear of infection, and race or ethnicity play a large role in whether or not people will get a COVID-19 vaccine, particularly when looking at socio-demographic factors.


August 9, 2021

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

Linda Haymes

“This offers an entirely new treatment option for relapsed myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D., Ph.D. “It is a whole new class of treatment; it’s like immunotherapy is coming of age.”

The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.


July 30, 2021

Cochlear Implant Surgery Restores Hearing, Improves Marriage

Linda Satter

From left, Beverly Holloway, Patrick Holloway and audiologist Matthew Brown, Au. D., at Patrick's May 4 appointment.

After 26 years of marriage, Beverly Holloway still had a lot she wanted to discuss with her husband, Patrick. But despite him taking the initiative six years earlier to obtain hearing aids, they were both frustrated that the devices were no longer working, despite repeated adjustments. Here they were in their golden years, which are…



Previous page Next page